ivabradine has been researched along with Coronary Heart Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gapon, LI; Kolesnikova, SN; Musikhina, NA; Petelina, TI; Utesheva, AB | 1 |
| Einecke, D | 2 |
| Lohmann, M | 1 |
| Fortmüller, U | 1 |
| Aksakal, E; Aksu, U; Gulcu, O; Kaymaz, C; Oduncu, V; Sevimli, S; Tanboğa, İH; Topçu, S; Ulusoy, FR | 1 |
| Poteshkina, NG; Troshina, AA | 1 |
| Füessl, HS | 1 |
| Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M | 1 |
| Böhm, M; Reil, JC | 1 |
| Ferrari, R; Ford, I; Fox, K; Steg, PG; Tendera, M | 1 |
| Bertolazzi, M; Macciò, S; Rognoni, A; Rognoni, G | 1 |
| Tardif, JC | 2 |
| Gensini, GF; Lanza, GA | 1 |
| Mach, F | 1 |
| Carbajal, EV; Deedwania, PC | 1 |
| Bruhn, C | 1 |
| Jung, W; Lauck, G; Manz, M; Omran, H; Reuter, M | 1 |
| Vilaine, JP | 1 |
| Hoppe, UC | 1 |
8 review(s) available for ivabradine and Coronary Heart Disease
| Article | Year |
|---|---|
The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients.
Topics: Aged; Atrial Fibrillation; Benzazepines; Cardiovascular Agents; Chi-Square Distribution; Coronary Disease; Female; Humans; Incidence; Ivabradine; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors | 2016 |
Ivabradine: cardiovascular effects.
Topics: Animals; Benzazepines; Cardiovascular Physiological Phenomena; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Heart Rate; Humans; Ivabradine; Myocardial Ischemia | 2009 |
Heart rate as a treatable cardiovascular risk factor.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzazepines; Coronary Disease; Evidence-Based Medicine; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Practice Guidelines as Topic; Prognosis; Quality of Life; Risk Factors | 2009 |
[Ivabradine, an I(f) current inhibitor--new treatment options in coronary heart disease].
Topics: Animals; Anti-Arrhythmia Agents; Benzazepines; Coronary Disease; Heart Conduction System; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Sinoatrial Node; Treatment Outcome; Ventricular Function | 2009 |
Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Coronary Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Ivabradine; Myocardial Revascularization; Nitrates; Piperazines; Ranolazine; Treatment Outcome | 2011 |
[Ivabradine: heart rate reduction in coronary heart disease and chronic heart failure].
Topics: Benzazepines; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Drug Interactions; Heart Failure; Heart Rate; Humans; Ivabradine | 2012 |
[The discovery of the selective If current inhibitor ivabradine (Procoralan): a new therapeutic approach to ischemic heart disease].
Topics: Benzazepines; Biological Clocks; Cardiotonic Agents; Coronary Disease; Electrophysiology; Humans; Ivabradine; Myocardial Ischemia | 2006 |
Clinical results of I(f) current inhibition by ivabradine.
Topics: Angina Pectoris; Benzazepines; Coronary Disease; Electrophysiology; Heart Failure; Heart Rate; Humans; Ion Channels; Ivabradine; Potassium; Sodium | 2007 |
6 trial(s) available for ivabradine and Coronary Heart Disease
| Article | Year |
|---|---|
[Cerebral blood flow and endothelial functional activity in patients with coronary heart disease and arterial hypertension during therapy with ivabradine in combination with perindopril].
Topics: Benzazepines; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Cerebrovascular Circulation; Coronary Disease; Drug Combinations; Electrocardiography; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Ivabradine; Male; Metoprolol; Middle Aged; Perindopril; Research Design; Treatment Outcome; Ultrasonography, Doppler | 2012 |
[Attaining therapy relevant goals with ivabradin].
Topics: Adrenergic beta-Antagonists; Benzazepines; Coronary Disease; Drug Therapy, Combination; Guideline Adherence; Heart Failure; Heart Rate; Humans; Ivabradine | 2014 |
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
Topics: Aged; Benzazepines; Cardiovascular Diseases; Coronary Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Prognosis; Proportional Hazards Models; Risk Factors; Tachycardia; Ventricular Dysfunction, Left | 2008 |
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Benzazepines; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Rate; Hospital Mortality; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Ventricular Dysfunction, Left | 2008 |
[The BEAUTIFUL study].
Topics: Benzazepines; Coronary Disease; Double-Blind Method; Humans; Ivabradine; Ventricular Dysfunction, Left | 2009 |
A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction.
Topics: Adult; Aged; Benzazepines; Cardiomyopathy, Dilated; Coronary Disease; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Ivabradine; Male; Middle Aged; Reference Values; Risk Assessment; Severity of Illness Index; Single-Blind Method; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
11 other study(ies) available for ivabradine and Coronary Heart Disease
| Article | Year |
|---|---|
[Symptomatic coronary heart disease. Therapy with a beta blocker and ivabradine combination].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Coronary Disease; Drug Therapy, Combination; Guideline Adherence; Heart Failure; Humans; Ivabradine; Survival Rate | 2014 |
[SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].
Topics: Benzazepines; Cause of Death; Coronary Disease; Disease Progression; Humans; Ivabradine; Randomized Controlled Trials as Topic; Survival Analysis | 2014 |
[Symptomatic coronary heart diseases. Combination therapy is successful in general practice].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Clinical Trials as Topic; Coronary Disease; Drug Combinations; Heart Rate; Humans; Ivabradine | 2014 |
[First fixed combination becomes available].
Topics: Angina Pectoris; Benzazepines; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol | 2016 |
[Anti-angina fixed combination is available].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Cardiovascular Agents; Combined Modality Therapy; Coronary Disease; Drug Combinations; Humans; Ivabradine; Metoprolol; Recurrence | 2016 |
[Increased physical capacity].
Topics: Angina Pectoris; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Combinations; Humans; Ivabradine; Metoprolol; Physical Fitness | 2016 |
[Coronary Heart Disease at the Patient With Metabolic Syndrome: Strategy of Antianginal Therapy].
Topics: Benzazepines; Cardiovascular Agents; Coronary Disease; Heart Rate; Humans; Ivabradine; Metabolic Syndrome | 2016 |
[Resting heart rate as prognostic parameter--a slow rate indicates strength].
Topics: Adrenergic beta-Antagonists; Atenolol; Benzazepines; Coronary Disease; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Heart Rate; Humans; Ivabradine; Multicenter Studies as Topic; Prognosis; Randomized Controlled Trials as Topic; Rest; Stroke; Survival Rate | 2008 |
BEAUTIFUL results--the slower, the better?
Topics: Adrenergic beta-Antagonists; Benzazepines; Coronary Disease; Heart Rate; Humans; Ivabradine; Randomized Controlled Trials as Topic; Tachycardia; Ventricular Dysfunction, Left | 2008 |
[Coronary heart disease. Rapid heart rate has an unfavorable prognosis].
Topics: Adrenergic beta-Antagonists; Aged; Benzazepines; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Heart Rate; Humans; Ivabradine; Prognosis; Sinoatrial Node; Survival Analysis | 2008 |
[Heart rate reduction as a therapeutic strategy: novel options].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzazepines; Coronary Disease; Electrocardiography; Heart Failure; Heart Rate; Humans; Ivabradine; Myocardial Contraction; Survival Rate | 2006 |